WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data…

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced the launch of a website dedicated to protecting patients from misleading litigation advertising. The Responsible Advertising for Patient Safety website aims to drive and…

WASHINGTON, D.C. – As part of the medtech industry’s ongoing mobilization to combat COVID-19, the Advanced Medical Technology Association® (AdvaMed®) today announced that through the Standards Alliance mechanism, a multi-year partnership…

The Advanced Medical Technology Association® (AdvaMed®) and StartX today announced a new partnership designed to provide medtech entrepreneurs within the StartX network exclusive access to AdvaMed®’s resources and expertise to…

WASHINGTON, D.C.– Expert insights from key FDA and CMS officials highlight the on-demand offerings of Week 3 at The Virtual The MedTech Conference, powered by AdvaMed®, covering topics on the…

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data…

WASHINGTON, D.C.– Week 2 of The Virtual The MedTech Conference, powered by AdvaMed®, brings an additional slate of on-demand content as the premier meeting of the medical technology community continues its…